Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.
暂无分享,去创建一个
F. Sigaux | J. Soulier | E. Clappier | H. Dombret | A. Baruchel | J. Meijerink | P. Van Vlierberghe | G. Menschaert | M. Pla | H. de Thé | T. Taghon | J. Buijs-gladdines | M. Delord | W. Van Loocke | I. André-Schmutz | F. Catez | Gabriel Thérizols | Jean-Jacques Diaz | W. Smits | L. Hernandez | S. Gachet | D. Briot | S. Quentin | E. Genescà | G. Meunier | D. Avran | C. Gazin | Tiama El-Chaar | J. Buijs-Gladdines | Willem K. Smits | Frédéric Catez | Stéphanie Gachet | Eulàlia Genescà | Wouter Van Loocke
[1] Hui Shen,et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer , 2019, Nature Communications.
[2] S. Ghaffari,et al. Mitochondria in the maintenance of hematopoietic stem cells: new perspectives and opportunities. , 2019, Blood.
[3] George Thomas,et al. Ribosome biogenesis in cancer: new players and therapeutic avenues , 2017, Nature Reviews Cancer.
[4] R. Slack,et al. Mitochondrial activity in the regulation of stem cell self-renewal and differentiation. , 2017, Current opinion in cell biology.
[5] T. Sanda,et al. Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia , 2017, Front. Oncol..
[6] Eyal Gottlieb,et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemic stem cells , 2017, Nature Medicine.
[7] Cheng Cheng,et al. THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.
[8] Didier Auboeuf,et al. Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism , 2017, Oncotarget.
[9] Sun Mi Park,et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells , 2017, Nature Genetics.
[10] O. Larsson,et al. Genome-wide analysis of differential translation and differential translational buffering using anota2seq , 2017, bioRxiv.
[11] M. Shipp,et al. Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets , 2016, Cell Death and Differentiation.
[12] O. Naveiras,et al. Specification of haematopoietic stem cell fate via modulation of mitochondrial activity , 2016, Nature Communications.
[13] Michaela Frye,et al. Stem cell function and stress response are controlled by protein synthesis , 2016, Nature.
[14] Yuri Motorin,et al. Illumina-based RiboMethSeq approach for mapping of 2′-O-Me residues in RNA , 2016, Nucleic acids research.
[15] Anders H. Lund,et al. Profiling of 2′-O-Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity , 2016, Nucleic acids research.
[16] P. Campbell,et al. Somatic mutation in cancer and normal cells , 2015, Science.
[17] Long Gao,et al. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. , 2015, Cell stem cell.
[18] F. Speleman,et al. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. , 2014, Blood.
[19] R. Young,et al. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element , 2014, Science.
[20] Marco Y. Hein,et al. A “Proteomic Ruler” for Protein Copy Number and Concentration Estimation without Spike-in Standards* , 2014, Molecular & Cellular Proteomics.
[21] S. Morrison,et al. Metabolic regulation of stem cell function , 2014, Journal of internal medicine.
[22] Marco Y. Hein,et al. Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.
[23] Jeffrey A. Magee,et al. Haematopoietic stem cells require a highly regulated protein synthesis rate , 2014, Nature.
[24] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[25] N. Sonenberg,et al. Control of Translation and miRNA-Dependent Repression by a Novel Poly(A) Binding Protein, hnRNP-Q , 2013, PLoS biology.
[26] W. Klapper,et al. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. , 2013, Blood.
[27] Stein Aerts,et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia , 2012, Nature Genetics.
[28] J. Aster,et al. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species , 2012, Nature Medicine.
[29] A. Ferrando,et al. The molecular basis of T cell acute lymphoblastic leukemia. , 2012, The Journal of clinical investigation.
[30] J. Soulier,et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. , 2012, Cell stem cell.
[31] F. Farzaneh,et al. Are snoRNAs and snoRNA host genes new players in cancer? , 2012, Nature Reviews Cancer.
[32] G. Giaever,et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. , 2011, Cancer cell.
[33] G. Semenza,et al. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. , 2011, Cell stem cell.
[34] A. Ferrando,et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia , 2011, Nature Genetics.
[35] J. Soulier,et al. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations , 2011, Leukemia.
[36] Andrew P. Stubbs,et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. , 2011, Cancer cell.
[37] F. Sigaux,et al. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse , 2011, The Journal of experimental medicine.
[38] R. Nadon,et al. Identification of differential translation in genome wide studies , 2010, Proceedings of the National Academy of Sciences.
[39] T. Hoang,et al. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. , 2010, Genes & development.
[40] B. Ebert,et al. Ribosomopathies: human disorders of ribosome dysfunction. , 2010, Blood.
[41] Julien Textoris,et al. Dysregulation of Ribosome Biogenesis and Translational Capacity Is Associated with Tumor Progression of Human Breast Cancer Cells , 2009, PloS one.
[42] M. Muckenthaler,et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. , 2009, Blood.
[43] E. Raetz,et al. Molecular pathogenesis of T-cell leukaemia and lymphoma , 2008, Nature Reviews Immunology.
[44] B. Nadel,et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. , 2007, Blood.
[45] Rob Pieters,et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia , 2007, Nature Genetics.
[46] F. Alt,et al. Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.
[47] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[48] E. Macintyre,et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. , 2004, Blood.
[49] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[50] T. Kiss. Small Nucleolar RNAs An Abundant Group of Noncoding RNAs with Diverse Cellular Functions , 2002, Cell.
[51] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[52] J. Yong,et al. SMN interacts with a novel family of hnRNP and spliceosomal proteins , 2001, The EMBO journal.
[53] J. Shuster,et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. , 2000, Blood.
[54] K. Gross,et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T‐cell malignancies in transgenic mice , 1997, The EMBO journal.
[55] Tamás Kiss,et al. Site-Specific Ribose Methylation of Preribosomal RNA: A Novel Function for Small Nucleolar RNAs , 1996, Cell.
[56] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[57] Leon D. Segal,et al. Functions , 1995 .
[58] M. Oshimura,et al. CHROMOSOMAL 6q- ANOMALY IN ACUTE LYMPHOBLASTIC LEUKÆMIA , 1976, The Lancet.
[59] T. Taghon,et al. Notch signaling during human T cell development. , 2012, Current topics in microbiology and immunology.